Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Eneuro|April 24, 2021
S1P2-Gα12 Signaling Controls Astrocytic Glutamate Uptake and Mitochondrial Oxygen ConsumptionDeepa Jonnalagadda, Yasuyuki Kihara, Richard Rivera, et al.
Blood|October 23, 2012
Platelet secretion is kinetically heterogeneous in an agonist-responsive mannerDeepa Jonnalagadda, Leighton T Izu, Sidney W Whiteheart
Annual Review of Pharmacology and Toxicology|January 10, 2019
Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other DisordersJerold Chun, Yasuyuki Kihara, Deepa Jonnalagadda, et al.
Biochimica Et Biophysica Acta|August 28, 2014
Granule-mediated release of sphingosine-1-phosphate by activated plateletsDeepa Jonnalagadda, Manjula Sunkara, Andrew J Morris, et al.
International Journal of Molecular Sciences|April 30, 2021
A Soluble Epoxide Hydrolase Inhibitor, 1-TrifluoromethoxyPhenyl-3-(1-Propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune EncephalomyelitisDeepa Jonnalagadda, Debin Wan, Jerold Chun, et al.
Frontiers in Cellular Neuroscience|September 8, 2022
CAQK, a peptide associating with extracellular matrix components targets sites of demyelinating injuriesCharly Abi-Ghanem, Deepa Jonnalagadda, Jerold Chun, et al.
Eneuro|September 27, 2018
A Functionally Defined In Vivo Astrocyte Population Identified by c-Fos Activation in a Mouse Model of Multiple Sclerosis Modulated by S1P Signaling: Immediate-Early Astrocytes (ieAstrocytes)Aran Groves, Yasuyuki Kihara, Deepa Jonnalagadda, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 5, 2022
Ponesimod inhibits astrocyte-mediated neuroinflammation and protects against cingulum demyelination via S1P1 -selective modulationYasuyuki Kihara, Deepa Jonnalagadda, Yunjiao Zhu, et al.
Frontiers in Cellular Neuroscience|July 5, 2022
Single-Nucleus RNA-seq of Normal-Appearing Brain Regions in Relapsing-Remitting vs. Secondary Progressive Multiple Sclerosis: Implications for the Efficacy of FingolimodYasuyuki Kihara, Yunjiao Zhu, Deepa Jonnalagadda, et al.
Cell Reports|December 8, 2023
FTY720 requires vitamin B12-TCN2-CD320 signaling in astrocytes to reduce disease in an animal model of multiple sclerosisDeepa Jonnalagadda, Yasuyuki Kihara, Aran Groves, et al.
Pageof 2